1. Home
  2. PKE vs VNDA Comparison

PKE vs VNDA Comparison

Compare PKE & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$20.60

Market Cap

389.4M

Sector

Industrials

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$6.69

Market Cap

289.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
VNDA
Founded
1954
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
389.4M
289.0M
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
PKE
VNDA
Price
$20.60
$6.69
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$14.00
AVG Volume (30 Days)
87.0K
1.3M
Earning Date
01-13-2026
10-29-2025
Dividend Yield
2.44%
N/A
EPS Growth
5.81
N/A
EPS
0.36
N/A
Revenue
$63,128,000.00
$212,074,000.00
Revenue This Year
N/A
$12.01
Revenue Next Year
N/A
$21.57
P/E Ratio
$57.01
N/A
Revenue Growth
7.63
11.12
52 Week Low
$11.97
$3.81
52 Week High
$21.52
$6.88

Technical Indicators

Market Signals
Indicator
PKE
VNDA
Relative Strength Index (RSI) 62.03 67.97
Support Level $20.20 $6.15
Resistance Level $21.20 $6.88
Average True Range (ATR) 0.65 0.43
MACD 0.16 0.15
Stochastic Oscillator 76.85 90.30

Price Performance

Historical Comparison
PKE
VNDA

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: